Ying Huang

Stock Analyst at B of A Securities

(1.39)
# 1391
Out of 5,319 analysts
47
Total ratings
60.00%
Success rate
12.77%
Average return
20 Stocks
Name Action Price Target Current % Upside Ratings Updated
VRTX Vertex Pharmaceutica...
Maintains: Strong Buy
555 567
489.1 15.93% 10 Mar 31, 2025
GILD Gilead Sciences
Maintains: Neutral
70 72
104.54 -31.13% 6 Feb 5, 2020
NLNK NewLink Genetics
Downgrades: Underperform
n/a
n/a n/a 4 Jan 3, 2019
EIDX Eidos Therapeutics
Maintains: Neutral
24 13
n/a n/a 2 Oct 1, 2018
ADRO Aduro Biotech
Maintains: Underperform
40 30
n/a n/a 4 Aug 2, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
51 47
29.11 61.46% 1 Jul 25, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
64 80
5.94 1246.8% 3 Jul 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 2 May 2, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
486
n/a n/a 1 Apr 23, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
34 40
0.66 5960.61% 2 Mar 8, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
3700 4360
4.14 105214.01% 1 Feb 22, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
135 115
2.86 3920.98% 2 Jan 24, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Jan 5, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Underperform
n/a
n/a n/a 2 Jan 5, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
26
n/a n/a 1 Nov 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
358 365
118.61 207.73% 1 Oct 18, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Underperform
102 73
n/a n/a 1 Oct 13, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
23 33
1.42 2223.94% 1 Sep 22, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
380
n/a n/a 1 Jul 24, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 1 Feb 1, 2017